Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.164ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.164NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.392ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.392ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.392ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.392NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.377ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.377ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.377ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.377NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.5.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.5.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.5.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.86 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.6.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FK.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FK.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used